Pinnacle Associates’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$60.2K Sell
61,105
-320
-0.5% -$315 ﹤0.01% 840
2025
Q1
$88.5K Sell
61,425
-750
-1% -$1.08K ﹤0.01% 812
2024
Q4
$137K Sell
62,175
-221,080
-78% -$486K ﹤0.01% 816
2024
Q3
$847K Buy
283,255
+1,956
+0.7% +$5.85K 0.01% 492
2024
Q2
$624K Sell
281,299
-3,905
-1% -$8.67K 0.01% 546
2024
Q1
$764K Buy
285,204
+1,949
+0.7% +$5.22K 0.01% 525
2023
Q4
$847K Sell
283,255
-5,868
-2% -$17.5K 0.01% 501
2023
Q3
$283K Buy
289,123
+39,285
+16% +$38.5K 0.01% 683
2023
Q2
$347K Buy
249,838
+3,225
+1% +$4.48K 0.01% 644
2023
Q1
$392K Buy
246,613
+7,857
+3% +$12.5K 0.01% 566
2022
Q4
$1.49M Sell
238,756
-3,860
-2% -$24K 0.03% 341
2022
Q3
$1.63M Sell
242,616
-14,618
-6% -$98K 0.04% 318
2022
Q2
$1.64M Sell
257,234
-2,549
-1% -$16.2K 0.04% 325
2022
Q1
$1.21M Buy
259,783
+3,980
+2% +$18.5K 0.02% 419
2021
Q4
$1.28M Sell
255,803
-5,156
-2% -$25.8K 0.02% 407
2021
Q3
$3.15M Sell
260,959
-10,245
-4% -$123K 0.06% 276
2021
Q2
$5.74M Buy
271,204
+4,193
+2% +$88.7K 0.1% 203
2021
Q1
$7.49M Sell
267,011
-27,685
-9% -$777K 0.14% 163
2020
Q4
$7.66M Buy
294,696
+38,213
+15% +$994K 0.16% 148
2020
Q3
$9.53M Sell
256,483
-11,200
-4% -$416K 0.23% 119
2020
Q2
$13.7M Sell
267,683
-1,830
-0.7% -$93.9K 0.34% 84
2020
Q1
$8.5M Sell
269,513
-46,376
-15% -$1.46M 0.26% 110
2019
Q4
$18.8M Buy
315,889
+72,560
+30% +$4.33M 0.41% 70
2019
Q3
$8.92M Buy
243,329
+55,780
+30% +$2.04M 0.21% 130
2019
Q2
$8.73M Buy
187,549
+7,225
+4% +$336K 0.2% 136
2019
Q1
$7.24M Sell
180,324
-3,355
-2% -$135K 0.16% 162
2018
Q4
$8.45M Sell
183,679
-8,415
-4% -$387K 0.22% 127
2018
Q3
$8.52M Sell
192,094
-31,977
-14% -$1.42M 0.18% 154
2018
Q2
$8.78M Sell
224,071
-408,060
-65% -$16M 0.18% 155
2018
Q1
$45.7M Sell
632,131
-27,672
-4% -$2M 0.9% 25
2017
Q4
$43.4M Sell
659,803
-58,010
-8% -$3.82M 0.83% 29
2017
Q3
$36M Sell
717,813
-16,640
-2% -$834K 0.66% 42
2017
Q2
$34M Sell
734,453
-36,165
-5% -$1.67M 0.65% 41
2017
Q1
$27.2M Buy
770,618
+654,138
+562% +$23.1M 0.52% 48
2016
Q4
$1.46M Buy
+116,480
New +$1.46M 0.03% 344